161302-40-5
Chemical Structure
BMS 186318
- CAS No.: 161302-40-5
- Formula:C36H54N4O9
- Molecular Weight:686.84
IUPAC Name: tert-butyl ((2S,3R)-4-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-4-phenylbutyl)amino)-3-hydroxy-1-(4-(2-morpholino-2-oxoethoxy)phenyl)butan-2-yl)carbamate
InChIKey: OQHZMGOXOOOFEE-SYQUUIDJSA-N
SMILES: CC(C)(C)OC(N[C@@H](CC1=CC=CC=C1)[C@H](O)CNC[C@@H](O)[C@H](CC2=CC=C(OCC(N3CCOCC3)=O)C=C2)NC(OC(C)(C)C)=O)=O
Biological Activity: BMS 186318 is an HIV protease inhibitor. BMS 186318 exhibits better anti-HIV efficacy when used in combination with reverse transcriptase inhibitors such as Stavudine (HY-B0116) and other protease inhibitors such as Saquinavir (HY-17007). BMS 186318 can be used in antiviral research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BMS 186318 | BMS 186318 is an HIV protease inhibitor. BMS 186318 exhibits better anti-HIV efficacy when used in combination with reverse transcriptase inhibitors such as Stavudine (HY-B0116) and other protease inhibitors such as Saquinavir (HY-17007). BMS 186318 can be used in antiviral research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
